Adam Chodobski

Adam Chodobski

Auto-generated profile, based on publicly available information

Adam Chodobski

Department of Clinical Neurosciences, Brown University Medical School, Providence, Rhode Island 02903

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2011 in Translational Stroke Research
Verified
Journal Article
Closed access
PDF file
ACAdam Chodobski
Adam Chodobski
BZBrian J. Zink
Brian J. Zink
JSJoanna Szmydynger-Chodobska
Joanna Szmydynger-Chodobska

1 January 2003 in Neuroscience
Verified
Journal Article
Closed access
ACA Chodobski
A Chodobski
ICI Chung
I Chung
EKEwa Koźniewska-Kołodziejska
Ewa Koźniewska-Kołodziejska
TIT Ivanenko
T Ivanenko
WCW Chang
W Chang
JSJ Szmydynger-Chodobska
J Szmydynger-Chodobska

27 December 2007 in Fluids and Barriers of the CNS
Verified
Journal Article
Open access
PDF file
JSJoanna Szmydynger-Chodobska
Joanna Szmydynger-Chodobska
CPCrissey L Pascale
Crissey L Pascale
APAndrew N Pfeffer
Andrew N Pfeffer
CCCassaundra Coulter
Cassaundra Coulter
ACAdam Chodobski
Adam Chodobski
Background: There is an increasing interest in using choroid plexus (CP) epithelial cell lines to study the properties of the blood-cerebrospinal fluid barrier (BCSFB). Currently, there are three major CP-derived cell lines available. Z310 and TR-CSFB3, two immortalized cell lines carrying the simian virus 40 large T-antigen gene, were derived from rat CP epithelium, whereas the CPC-2 cell line was derived from human CP carcinoma. Although these cell lines have previously been used in various functional studies, the expression of adherens junction (AJ) and tight junction (TJ) proteins in these epithelial cells has not been systematically studied. Accordingly, in the present study, we sought to characterize the expression of these junctional proteins in these three cell lines. Methods: The cells were grown in six-well cell culture plates. Reverse-transcriptase polymerase chain reaction, Western blotting, and immunocytochemistry were used to characterize the expression of AJ and TJ proteins in the CP cell lines. Results: Z310 and TR-CSFB3 cells expressed a TJ protein, occludin, and its cytosolic binding partner, zonula occludens 1, as well as an AJ protein, E-cadherin, and β-catenin, a cytoplasmic protein that interacts with E-cadherin. However, the expression of occludin and E-cadherin in TR-CSFB3 cells at both the mRNA and protein level was weaker than that found in Z301 cells. The immunocytochemical analysis also demonstrated that the staining pattern for these junctional proteins in TR-CSFB3 cells was discontinuous and the staining intensity was weaker than that observed in Z310 cells. The message for claudin 1 and claudin 2 was expressed at low levels in TR-CSFB3 cells and these cells were weakly immunopositive for claudin 1. In comparison, the message for these TJ proteins could not be detected in Z310 cells. CPC-2 cells expressed occludin, which was localized to areas of cell-cell contact, but the staining pattern for this TJ protein was found to be variable and irregular. Although CPC-2 cells expressed mRNA for claudin 1, claudin 2, and claudin 11, only claudin 1 was expressed at the protein level and it was localized to the nuclei rather than to areas of cell-cell contact. An AJ protein, E-cadherin, was also found to be mislocalized in CPC-2 cells, even though its cytosolic binding partner, β-catenin, was restricted to areas of cell-cell contact, as in normal CP. Conclusion: The three CP cell lines analyzed in this study vary considerably with regard to the expression of AJ and TJ proteins, which is likely reflected by different barrier properties of these in vitro models of BCSFB.

1 April 1998 in European Journal of Pharmacology
Verified
Journal Article
Closed access
ACAdam Chodobski
Adam Chodobski
JSJoanna Szmydynger-Chodobska
Joanna Szmydynger-Chodobska
CJConrad E Johanson
Conrad E Johanson

3 October 2008 in BMC Neuroscience
Verified
Journal Article
Open access
PDF file
CPChris Pickering
Chris Pickering
MHMaria Hägglund
Maria Hägglund
JSJoanna Szmydynger-Chodobska
Joanna Szmydynger-Chodobska
FMFernanda Marques
Fernanda Marques
JPJoana Almeida Palha
Joana Almeida Palha
HSHelgi Schiöth
Helgi Schiöth
GPR125 belongs to the family of Adhesion G protein-coupled receptors (GPCRs). A single copy of GPR125 was found in many vertebrate genomes. We also identified a Drosophila sequence, DmCG15744, which shares a common ancestor with the entire Group III of Adhesion GPCRs, and also contains Ig, LRR and HBD domains which were observed in mammalian GPR125.

8 September 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JMJohn Marshall
John Marshall
JSJoanna Szmydynger-Chodobska
Joanna Szmydynger-Chodobska
MRMengia S. Rioult-Pedotti
Mengia S. Rioult-Pedotti
KLKara Lau
Kara Lau
ACAndrea T. Chin
Andrea T. Chin
ACAdam Chodobski
Adam Chodobski
Brain-derived neurotrophic factor (BDNF), a key player in regulating synaptic strength and learning, is dysregulated following traumatic brain injury (TBI), suggesting that stimulation of BDNF signaling pathways may facilitate functional recovery. This study investigates whether CN2097, a peptidomimetic ligand which targets the synaptic scaffold protein, postsynaptic density protein 95, to enhance downstream signaling of tropomyosin-related kinase B, a receptor for BDNF, can improve neurological function after TBI. Moderate to severe TBI elicits neuroinflammation and c-Jun-N-terminal kinase (JNK) activation, which is associated with memory deficits. Here we demonstrate that CN2097 significantly reduces the post-traumatic synthesis of proinflammatory mediators and inhibits the post-traumatic activation of JNK in a rodent model of TBI. The recordings of field excitatory post-synaptic potentials in the hippocampal CA1 subfield demonstrate that TBI inhibits the expression of long-term potentiation (LTP) evoked by high-frequency stimulation of Schaffer collaterals, and that CN2097 attenuates this LTP impairment. Lastly, we demonstrate that CN2097 significantly improves the complex auditory processing deficits, which are impaired after injury. The multifunctionality of CN2097 strongly suggests that CN2097 could be highly efficacious in targeting complex secondary injury processes resulting from neurotrauma.